Collectively, these findings underscore the essential partnership between MAT1A and CCND1 in orchestrating NSCLC glycolysis and tumorigenesis, providing novel insights into the molecular mechanisms underpinning this metabolic reprogramming in cancer. The gene discussed is CCND1; the disease is non-small cell lung carcinoma.